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Chronic lead nephropathy
EDITORIAL
Granular contracted kidneys were recognized as regular
features of chronic lead intoxication during the late nine-
teenth and early twentieth centuries [1—5]. At that time,
however, increasing social consciousness resulted in legis-
lation to define safe limits of lead exposure in industry and
to control excessive lead absorption. Although the degree
of control varied widely, the high standard of industrial
hygiene in the most developed countries led to the virtual
disappearance of the previously recognized renal complica-
tions of chronic lead intoxication [6—9]. Thus, a medical
generation grew up that, never having seen severe industrial
lead intoxication, doubted whether it was able to induce
the previously recorded renal pathology. However, exam-
ples could still be found in less well developed countries
[10, 11], although, because published descriptions were
rarely in English, such reports tended to be overlooked.
The latter part of the twentieth century has seen great
emphasis upon the hazards of industrial pollution that has
led to a reawakening of interest in the problem of the
hazards of lead exposure [12], a more critical examination
of the danger to humans from prolonged excessive absorp-
tion and storage of lead [13, 14] and determination of the
maximum daily lead intake which is possible without the
development of disease [15].
Because there were always a few cases of acute lead
poisoning to be seen, and many of these showed a renal
lesion by the presence of aminoaciduria and phosphaturia
[16, 17], by cells in urine containing eosinophilic intra-
nuclear inclusions seen on microscopy 1181 and by a charac-
teristic acute toxic renal lesion demonstrated by biopsy[19],
there has never been any doubt that acute lead intoxication
could induce a proximal tubular lesion. Intranuclear in-
clusion bodies could be produced predictably and regularly
in experimental animals [20—23] and detailed study of the
nature of these inclusions has shown them to contain both
lead and protein [24]. Considerable controversy persisted,
however, as to whether prolonged lead absorption and in-
toxication could produce a chronic renal lesion and result
in the granular contracted kidneys which had been reported
by the nineteenth century workers. Such a doubt was
entirely reasonable because, as a disease, chronic lead
nephropathy had virtually disappeared from most of the
developed nations of the world, and these were the ones
contributing most to the world's medical literature.
© 1973, by the International Society of Nephrology.
1
However, a group of physicians in Queensland, Australia,
continued to see cases of chronic renal failure occurring
many years after an episode of acute lead poisoning in
childhood. They believed from their follow-up of such cases
that the chronic renal lesion was etiologically associated
with the earlier lead intoxication [25]. Queensland was in
a somewhat unique situation in that it was a Western
civilization which had developed in a tropical and sub-
tropical location. For coolness, houses were built on 8 foot
high stumps and were surrounded by wide open verandas,
often with wooden railings, which were painted with the
only paint available at that time—a paint based on lead
pigments. Because it was both a safe and cool place to
play, children frequently spent prolonged periods on these
verandas and could easily ingest over a period large amounts
of the lead paint which tended to powder and flake in the
hot sun and come off on the hands. Thus, acute lead
poisoning in childhood became a very common disease in
Queensland in the late nineteenth and early twentieth
centuries. Some twenty or more years later, a very high
incidence of chronic renal failure with granular contracted
kidneys was detected in Queensland, a rate which far
exceeded that in the rest of Australia. Case follow-up at that
time and a careful examination of possible etiological
features led several investigators [26—29] to conclude that
the increased incidence of chronic renal failure was a sequel
to renal damage resulting from long and continued lead
intoxication in childhood. This led the local medical associa-
tion to recommend the exclusion of lead from paints in
areas accessible to children and legislation to this effect
was introduced in 1922, although it took some years for
this legislation to have full effect. Subsequently, over a
thirty year period, there was a steady decline in the mortality
from renal failure in Queensland, until it approached that
in the other Australian states.
Further evidence for a lead etiology in this chronic
nephropathy was provided by a retrospective study of
several aspects of the problem by Henderson [30—33].
Comparison of the mortality statistics in Queensland and
other Australian states led to the conclusion that the excess
mortality from chronic nephritis in Queensland was ex-
plicable by the action of a nephrotoxic agent which had
affected Queensland children between 1870 and 1920, and
which could initiate renal changes leading—in 10 to
40 years— to death from chronic nephritis [311. In addition,
an extensive follow-up of the mortality and incidence of
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renal disease in over 400 persons who as children had been
admitted to the hospital in Brisbane between 1915 and 1935
with a diagnosis of lead poisoning disclosed a great in-
crease in mortality from renal and vascular disease. One
hundred and sixty-five had died, 108 from chronic nephritis
or hypertension; of the survivors, 17 had proteinuria and
hypertension and three had hypertension alone [30]. In a
later study, the lead content of bone was correlated with
the renal histology in patients dying with granular con-
tracted kidneys between 1952 and 1955, and this revealed
that, whereas the renal pathology in almost two-thirds of
the cases could not be ascribed to recognized causes, the
lead content of bone in these subjects with cryptogenic
nephritis was significantly greater than that in the other
patients with a chronic nephropathy of recognized cause
[32]. This latter finding led to acceptance of the hypothesis
that an elevation in the lead content of bone is a pre-
requisite for the diagnosis of chronic lead nephropathy.
However, a similar follow-up of cases of acute lead
poisoning in Boston and Baltimore [34, 35] failed to show
a similar incidence of late chronic renal damage, although
occasional cases similar to the Queensland patients were
seen. Moreover, the US cases failed to show an increase in
urinary lead after the administration of EDTA, a finding
which led Chishoim [35] to conclude that lead absorption
in the Queensland cases must have been of a much more
prolonged variety, whereas that in the US cases would have
been more acute. Many fascinating explanations for this
discrepancy come to mind, but further studies to elucidate
the precise reason have been precluded by the gradual
disappearance of the disease in Queensland. However, it may
be relevant that, in animal studies, the amount of lead
absorbed and the degree of lead toxicity may be modified
by a number of other factors, such as the level of dietary
calcium [36], the presence of iron deficiency [37], the ex-
posure to sunlight and the administration of Vitamin D
Fig. 1. The alteration in urinary lead excretion after the administration of calcium EDTA on Day 3. Group (A) were control subjects
Group (B) were patients with chronic lead nephropathy; Group (C) were patients with chronic renal insufficiency attributable to
causes other than childhood lead poisoning. This illustrates the prolongation of the EDTA-induced lead excretion by renal failure,
the considerable increase in lead excretion after EDTA in chronic lead nephropathy and the normal lead excretion pattern after
EDTA in renal disease not due to lead. [Modified from Aust Ann Med (1963) 12:316 and Emmerson [45] by permission of
Blackwell Scientific Publications]
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[38, 39]. These latter factors may explain the higher in-
cidence of acute lead poisoning in the summer in USA.
The controversy over the association between prolonged
lead exposure in man and the subsequent development of
chronic renal disease might have been more easily resolved
if a similar nephropathy could have been readily reproduced
in animals. With a few exceptions [40], early studies failed
to show the development of a chronic lesion, although the
dose of lead given and its duration were clearly critical.
However, focal scarring was seen in the remaining kidney
when unilateral nephrectomy was performed after the
administration of lead [41], and more recent study of the
problem by Goyer [42] has shown that the prolonged ad-
ministration of lead to rats predictably results in both
tubular atrophy and interstitial scarring, the morphological
appearances being similar to those seen in the kidneys of
persons with excessive past lead absorption.
In order to study renal function in the Queensland cases,
attempts at diagnosis of chronic lead nephropathy during
life were made [43] and the following criteria were suggested
as a basis for clinical diagnosis: 1) features of a long-
standing, slowly progressive chronic renal disease, 2) a mod-
erate to considerable degree of uniform contraction of both
kidneys, 3) definite evidence of excessive past lead absorp-
tion and 4) the exclusion of alternative causes for chronic
renal disease. A comparison of the urinary excretion of
lead after a standard infusion of calcium EDTA revealed
that a significantly greater increase in urinary lead excretion
occurred in subjects who had had lead poisoning in child-
hood and who exhibited the other criteria for a diagnosis
of chronic lead nephropathy than in subjects without such
a history or subjects with renal disease due to causes other
than lead (Fig. 1) [44]. It appeared that the processes of
renal failure had resulted in the mobilization of lead from
bone where it had remained since the episode of acute
lead poisoning and that an increased amount of tissue lead
was thereby made accessible to the chelating agent. The
pathological appearance of the Queensland kidneys is
characteristic but not pathognomonic, the essential feature
being a reduction in the number of functioning nephrons,
with hypertrophy of the remaining nephrons, and con-
siderable contraction and interstitial fibrosis (Fig. 2) [45].
The appearance is that of a kidney in which nephrons have
been destroyed and have subsequently disappeared without
trace.
Chronic lead nephropathy also came to be recognized in
other parts of the world. It was thought to be common in
lead workers in France [46] and Richet et al [47] described
details of the findings in the kidneys of eight Parisians who
demonstrated evidence of both low grade lead intoxication
Fig. 2. A comparison between sections taken from cortex to papilla in the kidneys of (A) chronic lead nephropathy, (B) chronic
glomerulonephritis and (C) a normal kidney (PAS stain x 3). The lead nephritic kidney shows coarse granularity with gross cortical
atrophy and interstitial fibrosis. The glomerulonephritic kidney shows large numbers of glomerular remnants, a uniform pattern of
involvement and moderate cortical atrophy. [From Emmerson, 1967 [45] by permission of Blackwell Scientific Publications]
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and a chronic renal lesion. These patients differed from the
Queensland patients in that their lead contact was a con-
tinuing one and lead toxicity had persisted, with intra-
nuclear inclusion bodies in renal tubular cells. Additional
reports of renal function and structure in chronic lead
nephropathy were published from Italy [48, 49], Rumania
[10, 50] and Yugoslavia [11, 51]. A remarkable similarity
to the picture of chronic lead nephropathy was also seen in
the nephropathy of "moonshine"1 drinkers in the southern
states of the USA [52, 53]. These subjects showed a pattern
of chronic renal failure with a protracted course and con-
tracted kidneys. Clear evidence of persistent lead intoxica-
tion, including intranuclear inclusion bodies in renal epi-
thelial cells, could usually be found. As the moonshine
contained many other possible nephrotoxins, lead could
not be proved to be the cause, but comparison with cases
of lead nephropathy elsewhere in the world suggested that
it was. The renal pathology was remarkably similar to
that seen in the Queensland cases of chronic lead nephro-
pathy, a diagnostic infusion of calcium EDTA provided
evidence of excessive lead storage in these subjects [54] and
other sensitive parameters of lead intoxication were posi-
tive [55].
Another aspect of similarity between these cases and those
in Australia (as well as with the cases of chronic lead in-
toxication described in the nineteenth century) was the
frequent association with gout. Emmerson [44] recorded
that 50 percent of his cases with chronic lead nephropathy
had, at one time or another, suffered from acute gouty
arthritis and that, unlike primary gout, this incidence was
the same in females as in males. Subsequent investigation
revealed that the disproportionate hyperuricemia of chronic
lead nephropathy in Queensland was due to a defect in
renal excretion of urate [43], an opinion originally proposed
by Garrod in 1876 [56]. Studies of urate kinetics in moon-
shine drinkers with gout [57] also confirmed a renal patho-
genesis for the hyperuricemia of that condition. Subsequent
attempts to determine the relative contribution of tubular
reabsorption and secretion to this reduction in urate ex-
cretion have, within the limitations determined by the
interpretation of alterations in urate excretion following
pyrazinamide, suggested the presence of excessive tubular
reabsorption of urate as the cause for the undue hyper-
uricemia in lead nephropathy [58]. The implications from
this finding that there may be a reduced circulating plasma
volume in these subjects has not been followed further
because of the paucity of surviving subjects with lead
nephropathy. However, it would be consistent with the
suggestion [59] that lead may also have an effect upon the
renin-angiotensin-aldosterone system.
None of these studies individually can be said to provide
conclusive proof of an etiological relationship between
prolonged lead absorption and chronic renal disease. The
combined evidence, however, is such as to make a cause
Illicitly distilled liquor.
and effect relationship highly likely. It would seem that
little more can be done to establish further this relationship
in man, except that an awareness of the possibility of
chronic lead nephropathy and an appropriate search for it
in suitable cases, either by the measurement of the lead
content of bone [60] or the urinary lead excretion following
an EDTA infusion [44], may lead to the establishment of
this diagnosis in cases of otherwise undiagnosable chronic
renal disease.
Bryan T. Emmerson
Queensland, Australia
Reprint requests to Dr. B. T. Emn,erson, Department of
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